SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-049747
Filing Date
2021-04-13
Accepted
2021-04-13 16:01:49
Documents
13
Period of Report
2021-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2112858d1_8k.htm   iXBRL 8-K 26872
2 EXHIBIT 10.1 tm2112858d1_ex10-1.htm EX-10.1 8440
  Complete submission text file 0001104659-21-049747.txt   214063

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrns-20210409.xsd EX-101.SCH 3202
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20210409_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20210409_pre.xml EX-101.PRE 22721
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2112858d1_8k_htm.xml XML 3735
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 21823089
SIC: 2834 Pharmaceutical Preparations